
Hepatic artery infusion chemotherapy was introduced to treat non-resectable liver metastases or tumors. Although growth patterns of hepatic metastases and pharmacokinetics of cytostatics are well known, the response rate to intraarterial chemotherapy amounts to a maximum of 50% only, the mean survival time being 1 year or less. Until now, complete healing was not observed. Future efforts should be directed at increasing the response rate, decreasing regional adverse side effects and avoiding extrahepatic disease.
Catheters, Indwelling, Hepatic Artery, Antineoplastic Combined Chemotherapy Protocols, Liver Neoplasms, Hepatectomy, Humans, Infusions, Intra-Arterial, Fluorouracil, Floxuridine
Catheters, Indwelling, Hepatic Artery, Antineoplastic Combined Chemotherapy Protocols, Liver Neoplasms, Hepatectomy, Humans, Infusions, Intra-Arterial, Fluorouracil, Floxuridine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
